Clinical Trial: Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDER

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title:

Brief Summary: The purpose of this feasibility study is to investigate the safety of the AMPLATZER® Membranous VSD Occluder for the treatment of hemodynamically significant Perimembranous Ventricular Septal Defects.

Detailed Summary:
Sponsor: St. Jude Medical

Current Primary Outcome: Closure of perimembranous Ventricular Septal Defects [ Time Frame: 5 years ]

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: St. Jude Medical

Dates:
Date Received: December 20, 2007
Date Started: September 2003
Date Completion:
Last Updated: March 16, 2015
Last Verified: March 2015